Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 1 5Phase 3 4Phase NA 3Phase EARLY_PHASE1 3Phase 4 3Phase 1/2 2Phase 2/3 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 9Breast 3Head & Neck 2Genitourinary 2Gynecologic 1

Conditions

Breast Neoplasms 2Racism 1Insulin Resistance 1Breast Cancer Female 1

Interventions

Letrozole 23Docetaxel 17Cyclophosphamide 13Zoledronic Acid 12Trastuzumab 12Anastrozole 12exemestane 11Tamoxifen 11Paclitaxel 11Capecitabine 10Fulvestrant 8Epirubicin 8pegfilgrastim 7Saline Solution 7Bupivacaine 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Sodium Chloride 6Filgrastim 6Carboplatin 6pegylated granulocyte colony-stimulating factor 5palbociclib 5Ropivacaine 5Dexmedetomidine 5Bevacizumab 5ribociclib 4eribulin 4Vinorelbine 4Tranexamic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Metformin × Breast × Clear all
NCT04741204 2023-07-06

METBC

Woman's

Phase 4 Withdrawn
Breast

Breast Neoplasms, Insulin Resistance, Racism

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Beni-Suef University

Phase 4 Completed
107 enrolled
Breast

Breast Neoplasms

NCT05507398 2022-10-31

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

Tanta University

Phase 4 Unknown
100 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡